Use of trastuzumab emtansine (T-DM1; K) after pertuzumab + trastuzumab (PH) in patients with HER2-positive metastatic breast cancer (mBC): Challenges in assessing effectiveness of treatment sequencing in the real world (RW)
医学
内科学
转移性乳腺癌
队列
耐受性
曲妥珠单抗
帕妥珠单抗
乳腺癌
癌症
胃肠病学
不利影响
作者
Thibaut Sanglier,Alessandra Fabi,C. Flores,Evelyn M. Flahavan,Nicolas Lindegger,Filippo Montemurro